Back to DRUG

GOLDMAN SACHS GROUP INC → DRUG

GOLDMAN SACHS GROUP INC DRUG Position History

Bright Minds Biosciences Inc. • Healthcare

Quarters held
9
Latest value
$4.9M
Q3 2026
Peak value
$6.4M
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$802K
Q4 2025$3.8M
Q4 2025$3.8M
Q1 2026$3.4M
Q1 2026$2.1M
Q2 2026$3M
Q2 2026$6.4M
Q3 2026$1.8M
Q3 2026$4.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4.9M99.3K——
Q3 2026$1.8M35.8K——
Q2 2026$6.4M91.3K——
Q2 2026$3M42.4K——
Q1 2026$2.1M28.4K——
Q1 2026$3.4M46.0K——
Q4 2025$3.8M48.5K——
Q4 2025$3.8M48.5K——
Q1 2025$802K22.2K——

Other funds holding DRUG

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B